70: Defibrotide for the treatment of Sinusoidal Obstruction Syndrome (SOS) following hematopoietic stem cell transplant in pediatric patients
| dc.contributor.author | Hill, A.B. | |
| dc.contributor.author | Robertson, K.A. | |
| dc.contributor.author | Gowan, D.J. | |
| dc.contributor.author | Lorch, C. | |
| dc.contributor.author | Collura, J.M. | |
| dc.contributor.author | Renbarger, J. | |
| dc.contributor.author | Goebel, W.S. | |
| dc.contributor.author | Haut, P.P. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2021-02-16T16:24:08Z | |
| dc.date.available | 2021-02-16T16:24:08Z | |
| dc.date.issued | 2007-02-01 | |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Hill, A. B., Robertson, K. A., Gowan, D. J., Lorch, C., Collura, J. M., Renbarger, J., ... & Haut, P. P. (2007). 70: Defibrotide for the treatment of Sinusoidal Obstruction Syndrome (SOS) following hematopoietic stem cell transplant in pediatric patients. Biology of Blood and Marrow Transplantation, 13(2), 28-29. | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/25241 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.bbmt.2006.12.073 | en_US |
| dc.relation.journal | American Society for Blood and Marrow Transplantation | en_US |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Publisher | en_US |
| dc.subject | Treatment | en_US |
| dc.subject | Sinusoidal Obstruction Syndrome | en_US |
| dc.subject | hematopoietic stem cell transplant | en_US |
| dc.title | 70: Defibrotide for the treatment of Sinusoidal Obstruction Syndrome (SOS) following hematopoietic stem cell transplant in pediatric patients | en_US |
| dc.type | Article | en_US |